Overexpression of DNA-methyltransferases, including DNMT3B, at both the mRNA and protein level has been described for several malignancies, including prostate, lung, breast, and colorectal cancer; glioblastoma; and leukemia [43,44,45,46,47]. This evidence concerns the gene DNMT3B and leukemia.